Magdalena B. Wozniak

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi et al. · The Lancet · 2023 · 270 citations

Inflammation, Double-blind Phase 3, Week 16 +5

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

Ghislaine Scélo, Yasser Riazalhosseini, Liliana Greger et al. · Nature Communications · 2014 · 196 citations · Full text

Urology, Genitourinary Cancer, Tumor Heterogeneity +9

Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States

Magdalena B. Wozniak, Florence Le Calvez‐Kelm, Behnoush Abedi‐Ardekani et al. · PLoS ONE · 2013 · 169 citations · Full text

Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer

Magdalena B. Wozniak, Ghislaine Scélo, David C. Muller et al. · PLoS ONE · 2015 · 144 citations · Full text

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma

Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff et al. · Haematologica · 2010 · 105 citations · Full text